Barbro Ehlin‐Henriksson

Author

Karolinska Institutet

Also Known As

B Ehlin-Henriksson, B. Ehlin-Henriksson, B. Ehlin‐Henriksson, Barbro Ehlin-Henriksson, Barbro Ehlin‐Henriksson

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Children's Hospital of Philadelphia Karolinska University Hospital Xiangya Hospital Central South University Central South University

About

Barbro Ehlin‐Henriksson is an author at Karolinska Institutet specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.3K
2	Immunology	16	21	1.3K
3	Cell Biology	15	17	1.1K
4	Pathology	14	17	1.1K
5	Allergy	2	2	219

Barbro Ehlin‐Henriksson

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Raymond Frade, Monique Barel, Barbro Ehlin‐Henriksson, Proceedings of the National Academy of Sciences AllergyAutoimmune DiseaseEbv BindingMedicineEpstein-barr Virus Receptor	1985	193
Epstein-Barr virus susceptibility of normal human B lymphocyte populations. Pierre Åman, Barbro Ehlin‐Henriksson, George Klein The Journal of Experimental Medicine High DensityLymphoid NeoplasiaViral ReplicationViral PersistenceEbv Bound	1984	192
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes Staffan Paulie, Barbro Ehlin‐Henriksson, H�kan Mellstedt, Cancer Immunology Immunotherapy HistocompatibilityUrologyGenitourinary CancerImmunologyImmunoediting	1985	166
Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Joakim Dillner, Lars Sternås, Bengt Kallin, Proceedings of the National Academy of Sciences	1984	109
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Bengt Kallin, Joakim Dillner, Ingemar Ernberg, Proceedings of the National Academy of Sciences ImmunologyEpstein-barr Virus-transformed CellsPathologyAntigen ProcessingImmunotherapy	1986	105
Burkitt’s Lymphoma Is a Malignancy of Mature B Cells Expressing Somatically Mutated V Region Genes Ulf Klein, George Klein, Barbro Ehlin‐Henriksson, Molecular Medicine Lymphoid NeoplasiaImmunologyPathologyAdult T-cell Leukemia-lymphomaMedicine	1995	99
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Sigurbjörg Torsteinsdóttir, Maria G. Masucci, Barbro Ehlin‐Henriksson, Proceedings of the National Academy of Sciences HistocompatibilityBurkitt Lymphoma LinesLymphocyte DevelopmentImmunologyPathology	1986	94
The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. Staffan Paulie, Antony Rosen, Barbro Ehlin‐Henriksson, The Journal of Immunology ImmunologyPathologyImmunologic MechanismAntigen ProcessingImmunotherapy	1989	91
Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. László Székely, Gunnar O. Klein, Norihiro Teramoto, Journal of General Virology	1998	86
Capacity of B‐lymphocytic lines of diverse tumor origin to produce and respond to B‐cell growth factors: A progression model for B‐cell lymphomagenesis John Gordon, Pierre Åman, Anders Rosén, International Journal of Cancer	1985	58

Page 1